SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.34 -0.07
(-0.08%)

EUR-INR

110.08 -0.10
(-0.09%)

GBP-INR

127.59 -0.01
(-0.01%)

JPY-INR

0.59 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fermenta Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506414

INE225B01021

143.7924911

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

FERMENTA

16.82

997.12

EPS(TTM)

Face Value()

Div & Yield %

20.14

1.08

Back

NCL Research and Financial Services reports standalone net profit of Rs 0.41 crore in the December 2025 quarter

Feb 06,2026

Net profit of NCL Research and Financial Services reported to Rs 0.41 crore in the quarter ended December 2025 as against net loss of Rs 0.38 crore during the previous quarter ended December 2024. Sales declined 41.64% to Rs 2.13 crore in the quarter ended December 2025 as against Rs 3.65 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2.13	3.65	-42
OPM %	27.23	23.84	-
PBDT	0.58	-0.33	LP
PBT	0.57	-0.35	LP
NP	0.41	-0.38	LP

75,527.95 1,695.40 ( 2.30%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.34 -0.07 (-0.08%)

110.08 -0.10 (-0.09%)

127.59 -0.01 (-0.01%)

0.59 0.00 (-0.20%)